Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …

Objectives: This study sought to assess the efficacy of angiotensin-converting enzyme
inhibitors (ACEIs) in patients with coronary heart disease and preserved left ventricular (LV) …

Objectives To compare the efficacy and safety of angiotensin-converting enzyme inhibitors
(ACEis) and angiotensin receptor blockers (ARBs) in patients without heart failure. Patients …

Background Results of randomized trials of angiotensin-converting enzyme inhibitors in
patients with coronary artery disease (CAD) and preserved left ventricular function are …

Background: The role of angiotensin-receptor blockers (ARBs) in treating patients with
chronic heart failure and high-risk acute myocardial infarction (MI) has been controversial …

OBJECTIVE: To determine, through a review of the medical literature, whether there is
adequate evidence to support the use of angiotensin receptor blockers (ARBs) in place of …

In this article, 2 leading physicians debate the strength of outcome data on the efficacy of
angiotensin-converting enzyme (ACE) inhibitors versus angiotensin II receptor blockers …

The renin angiotensin aldosterone system (RAAS) plays a central role in the
pathophysiology of hypertension and vascular disease. Angiotensin converting enzyme …

The renin-angiotensin-aldosterone system (RAAS) is essential for the regulation of blood
pressure, cardiovascular and renal function. Drugs inhibiting the RAAS, particularly …

Context. Whether angiotensin converting‐enzyme inhibitors (ACEI) and angiotensin‐
receptor blockers (ARB) are useful in high risk patients without heart failure is unclear. We …